Prevalence of ESR1 Mutation in Chinese ER-Positive Breast Cancer

BACKGROUND: ESR1 mutation and its possible relation to endocrine therapy resistance in ER-positive breast cancers have been studied with respect to genetic sequencing data from Western patients but rarely from Chinese patients. This study aimed to investigate the prevalence of ESR1 mutation in Chine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wenzhen, Ren, Chongyang, Wang, Yulei, Wen, Lingzhu, Zhang, Guochun, Liao, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982432/
https://www.ncbi.nlm.nih.gov/pubmed/32021303
http://dx.doi.org/10.2147/OTT.S233662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982432/
https://www.ncbi.nlm.nih.gov/pubmed/32021303
http://dx.doi.org/10.2147/OTT.S233662

Ejemplares similares